Literature DB >> 27575762

Fluocinolone Implant Forceps: Instrument Modification for Enhanced Implant Insertion.

Samuel Burke, Thomas A Albini, Juan D Silgado, Basil K Williams, Jean-Marie A Parel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27575762      PMCID: PMC5006688          DOI: 10.1097/IIO.0000000000000135

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  11 in total

1.  Spontaneous dislocation of fluocinolone acetonide implant pellets from their suture struts.

Authors:  Sujit Itty; David Callanan; Racheal Jones; Paula Pecen; Joseph Martel; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2015-01-30       Impact factor: 5.258

2.  Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.

Authors:  Glenn J Jaffe; Daniel Martin; David Callanan; P Andrew Pearson; Brian Levy; Timothy Comstock
Journal:  Ophthalmology       Date:  2006-05-09       Impact factor: 12.079

3.  Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

Authors:  John H Kempen; Michael M Altaweel; Janet T Holbrook; Douglas A Jabs; Thomas A Louis; Elizabeth A Sugar; Jennifer E Thorne
Journal:  Ophthalmology       Date:  2011-08-15       Impact factor: 12.079

4.  Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants.

Authors:  Clovis Arcoverde Freitas-Neto; Armin Maghsoudlou; Swetha Dhanireddy; Abhishek Payal; Sutasinee Boonsopon; Malinga D Ratwatte; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2014-12-26       Impact factor: 3.070

5.  Spontaneous dislocation of a fluocinolone acetonide implant (Retisert) into the anterior chamber and its successful extraction in sympathetic ophthalmia.

Authors:  David R P Almeida; Eric K Chin; Katrina Mears; Stephen R Russell; Vinit B Mahajan
Journal:  Retin Cases Brief Rep       Date:  2015

6.  Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.

Authors:  Janet T Holbrook; Elizabeth A Sugar; Alyce E Burke; Albert T Vitale; Jennifer E Thorne; Janet L Davis; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2015-12-31       Impact factor: 5.258

7.  Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery.

Authors:  Benjamin P Nicholson; Rishi P Singh; Jonathan E Sears; Careen Y Lowder; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2012-09-13       Impact factor: 5.258

8.  Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.

Authors:  Carlos Pavesio; Manfred Zierhut; Khaled Bairi; Timothy L Comstock; Dale W Usner
Journal:  Ophthalmology       Date:  2010-01-15       Impact factor: 12.079

9.  Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.

Authors:  David G Callanan; Glenn J Jaffe; Daniel F Martin; P Andrew Pearson; Timothy L Comstock
Journal:  Arch Ophthalmol       Date:  2008-09

Review 10.  Sustained-release corticosteroid options.

Authors:  Mariana Cabrera; Steven Yeh; Thomas A Albini
Journal:  J Ophthalmol       Date:  2014-07-23       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.